Cancer Biomarkers

A Cancer biomarker alludes to a substance or process that has the characteristic of the nearness of malignancy in the body. A biomarker might be a molecule discharged by a tumor or a particular reaction of the body to the nearness of disease. Hereditary, epigenetic, proteomic, glycomic, and other biomarkers can be utilized for malignant growth finding, guess, and the study of disease transmission. In a perfect world, such biomarkers can be measured in non-intrusively gathered biofluids like blood or serum

In Cancer research, Biomarkers can be used in 3 important ways:

1. To help analyze conditions, as on account of distinguishing beginning time malignant growths (Diagnostic)

 

2. To figure how forceful a condition is, as on account of deciding a patient's capacity to passage without treatment (Prognostic)

 

3. To anticipate how well a patient will react to treatment (Predictive)

    Related Conference of Cancer Biomarkers

    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    September 14-15, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    September 28-29, 2026

    13th International Conference on Stroke and Neurological Disorders

    Amsterdam, Netherlands
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    January 18-19, 2027

    44th International Conference on Women's Health

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in